ARYA Sciences Acquisition Corp. III (ARYA)
Stock Price:
$10.75 USD
-0.06 (-0.56%)
Updated Sep 17, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
166.08M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
n/a |
| Shares Out |
15.45M |
| EPS (ttm) |
-0.08 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Sep 17, 2020 |
| Last Price |
$10.75 |
| Previous Close |
$10.81 |
| Change ($) |
-0.06 |
| Change (%) |
-0.56% |
| Day's Open |
10.80 |
| Day's Range |
10.75 - 10.86 |
| Day's Volume |
18,404 |
| 52-Week Range |
10.30 - 11.84 |
More Stats
| Market Cap |
166.08M |
| Enterprise Value |
n/a |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
15.45M |
| Float |
n/a |
| EPS (basic) |
n/a |
| EPS (diluted) |
-0.08 |
| FCF / Share |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
19,771 |
| Short Ratio |
0.01 |
| Short % of Float |
0.01% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
1.94 |
| Revenue |
n/a |
| Operating Income |
n/a |
| Net Income |
n/a |
| Free Cash Flow |
n/a |
| Net Cash |
n/a |
| Net Cash / Share |
0.00 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-0.33% |
| ROE |
51.57% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
29.2
Current: $10.75
High
29.2
Target: 29.24
*Average 12-month price target from 1 stock analysts.
Financial Overview
No financial data available for this stock yet.
Company Details
| Full Name |
ARYA Sciences Acquisition Corp. III |
| Country |
United States |
| CEO |
Adam Stone |
Stock Information
| Ticker Symbol |
ARYA |
| Stock Exchange |
NASDAQ |
| Sector |
Financial Services |
| Industry |
Shell Companies |
| Unique Identifier |
NASDAQ: ARYA |
| IPO Date |
August 7, 2020 |
Description
ARYA Sciences Acquisition Corp III intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2020 and is based in New York, New York. Address: 51 Astor Place, New York, NY, United States, 10003